Capillary Electrophoresis–Mass Spectrometry in Metabolomics: The Potential for Driving Drug Discovery and Development

Author(s): Xu Wang, Kefeng Li, Erwin Adams, Ann Van Schepdael

Journal Name: Current Drug Metabolism

Volume 14 , Issue 7 , 2013

Become EABM
Become Reviewer
Call for Editor


Metabolomics represents the global profiling of metabolites in a given biological system. It has been used to facilitate pharmaceutical discovery and development for over a decade. Advances in instrumentation have positioned capillary electrophoresis–mass spectrometry (CE-MS) as an important platform for both targeted and non-targeted metabolomics. In this mini-review covering the last five years, we focus on the latest development of CE-MS based metabolomics in (a) identification and validation of novel valuable therapeutic targets, (b) evaluation of drug efficacy, and (c) monitoring of drug unanticipated adverse effects. Some of the current issues and future directions of CE-MS metabolomics are also discussed in the end.

Keywords: Biomarkers, CE-MS, drug discovery and development, drug efficacy, drug toxicity metabolomics.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 30 August, 2013
Page: [807 - 813]
Pages: 7
DOI: 10.2174/13892002113149990101
Price: $65

Article Metrics

PDF: 16